She is based in the Berlin office and will further strengthen the firm’s global Healthcare and Life Sciences sector, which is growing around the world and advising clients on a wide range of critical financial, political, and social issues.
Carri has worked for much of her distinguished career in the public and private capital markets, with a focus on the Healthcare and Life Sciences sector. Most recently, Carri ran her own consultancy, sourcing healthcare investment opportunities for private capital firms and global family foundations, as well as providing strategic advice on reputation and stakeholder management to healthcare and life sciences companies. Her prior experience includes serving as a senior Investor Relations professional at Bayer, as a consultant at Egon Zehnder, in investment banking roles at Sal Oppenheim-Macquarie and as a pioneer to buy-side Biotech equity coverage at Credit Suisse.